CBAI Financials 07/16/2014 03:28:08 Cord Blood Am

CBAI Financials 07/16/2014 03:28:08
Cord Blood America, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 5,975 5,993 5,075 4,128
Cost of Revenue 2,004 1,794 1,562 1,622
Gross Profit 3,971 4,199 3,510 2,506
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 5,117 5,444 6,999 8,311
Non-Recurring Items - - 141 869
Other - - - -
Operating Income (1,146) (1,244) (3,631) (6,673)
Income From Continuing Operations
Add'l Income/Expense Items - 118 - -
Earnings Before Interest and Tax (1,146) (1,127) (3,631) (6,673)
Interest Expense 1,894 1,268 2,240 1,779
Earnings Before Tax (3,041) (2,395) (5,871) (8,452)
Income Tax (62) - - -
Minority Interest (512) (218) (539) (359)
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (2,979) (2,395) (5,871) (8,093)
Non Recurring Events
Discontinued Operations - (1,101) (639) -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (2,467) (3,277) (5,972) (8,093)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (2,467) (3,277) (5,972) (8,093)